The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Co announces the presentation of preclinical data using antagonists of Toll-like receptor 7 and 9 in mouse models of lupus disease. "The antagonist candidates studied in mouse lupus models have been ...
Dermatologists long reluctant to tackle cutaneous lupus erythematosus may be more open to treating patients with approvals ...
SAN DIEGO--(BUSINESS WIRE)--Primmune Therapeutics today announced the initial closing of a $27.4 million Series A financing to advance the development of novel orally-administered, small molecule toll ...
Toll-like receptor (TLR) and saponin adjuvants have each improved vaccine potency and safety. Now, researchers at Stanford University report that combining them in a nanoparticle format improves not ...
Innovent Biologics (Suzhou) Co. Ltd. has described antibody-stimulating antibody conjugates (ISACs) comprising antibody targeting folate receptor α (FOLR1; FR-α) or tumor-associated calcium signal ...
Co announces the presentation of preclinical data using its proprietary antagonists of Toll-like receptors 7 and 9 in mouse models of collagen-induced arthritis, a commonly used model for rheumatoid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback